squamous cell carcinoma

Skin toxicities caused by targeted therapies

Number 53

Grandround 1 March 2013 0

Targeted drugs can result in a variety of skin toxicities that are unpleasant for patients and, if unattended to, can lead them to stop taking their drug as prescribed. Effective teamwork is required to ensure [more]

Cetuximab therapy for patients with advanced squamous cell carcinomas of the head and neck

Number 30

Impact Factor 1 May 2009 0

Cetuximab increases overall survival in patients with recurrent or metastatic squamous cell carcinomas of the head and neck. Reasonable treatment strategies include the use of first-line platinum, 5-fluorouracil and cetuximab combination, or cetuximab used following [more]